NON-HODGKIN'S LYMPHOMA

Clinical trials for NON-HODGKIN'S LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new NON-HODGKIN'S LYMPHOMA trials appear

Sign up with your email to follow new studies for NON-HODGKIN'S LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 18 Not yet recruiting 1 Not yet finished but already full! 13 Completed 5 Terminated 1

Drug combo aims to control Slow-Growing lymphoma without chemo

Disease control Terminated

This phase 2 study tested a combination of two drugs, lenalidomide and rituximab, in 30 people with previously untreated indolent non-Hodgkin's lymphoma. The goal was to see how well the drugs worked together to shrink or control the cancer. Participants took lenalidomide daily f…

Matched conditions: NON-HODGKIN'S LYMPHOMA

Phase: PHASE2 • Sponsor: University of California, Davis • Aim: Disease control

Last updated Jun 27, 2026 07:59 UTC

NON-HODGKIN'S LYMPHOMA

Get alerted when new NON-HODGKIN'S LYMPHOMA trials appear

Drug combo aims to control Slow-Growing lymphoma without chemo